Anti-MSH2 抗体 [EPR21017-123]
Anti-MSH2 antibody [EPR21017-123]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(16 Publications)
Rabbit Recombinant Monoclonal MSH2 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 16 publications.
別名を表示する
DNA mismatch repair protein Msh2, hMSH2, MutS protein homolog 2, MSH2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Immunohistochemical analysis of paraffin-embedded human testis tissue labeling MSH2 with ab227941 at 1/8000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Nuclear staining in human testis was observed (PMID : 10029069). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed, 90% methanol-permeabilized A-375 (humanmalignant melanoma cell line) cell line labeling MSH2 with ab227941 at 1/600 dilution (red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Overlay histogram showing HAP1 wildtype (green line) and HAP1-MSH2 knockout cells (red line) stained with ab227941. The cells were fixed with 80% methanol (5 min) (left panel) or 4% formaldehyde (10 min) (right panel) , and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS / 10% normal goat serum to block non-specific protein-protein interactions followed by ab227941 for 30 min at 22°C. The secondary antibody used was Alexa Fluor® 488 goat anti-rabbit IgG (H&L) presorbed (ab150081) at 1/2000 dilution for 30 min at 22°C.
A rabbit IgG isotype control antibody (ab172730) was used at the same concentration and conditions as the primary antibody (HAP1 wildtype - black line, HAP1-MSH2 knockout - grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity).
Acquisition of >5,000 events were collected using a 50 mW Blue laser (488nm) and 530/30 bandpass filter.
Note : We recommend fixing cells using MeOHinstead of PFA toget optimal results.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Immunohistochemical analysis of paraffin-embedded human colon cancer tissue labeling MSH2 with ab227941 at 1/8000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP). Nuclear staining in para-carcinoma colonic epithelium (image B) or stromal cells (both image A and B) and loss of expression in the paired colon cancer (image A) (PMID : 24710284). Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Immunofluorescent analysis of 100% methanol-fixed A-375 (human malignant melanoma cell line) cells labeling MSH2 with ab227941 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Nuclear staining in A-375 cell line is shown.
The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Immunofluorescent analysis of 100% methanol-fixed A549 (human lung carcinoma cell line) cells labeling MSH2 with ab227941 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Nuclear staining in A549 cell line is shown.
The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- IP
Unknown
Immunoprecipitation - Anti-MSH2 antibody [EPR21017-123] (AB227941)
MSH2 was immunoprecipitated from 0.35 mg of A-375 (human malignant melanoma cell line) lysate with ab227941 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab227941 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.
Lane 1 : A-375 whole cell lysate 10 μg (Input).
Lane 2 : ab227941 IP in A-375 whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab227941 in A-375 whole cell lysate.
Exposure time : 1 second.
Blocking and dilution buffer concentration : 5% NFDM/TBST.
All lanes:
Immunoprecipitation - Anti-MSH2 antibody [EPR21017-123] (ab227941)
Predicted band size: 105 kDa
Observed band size: 105 kDa
true
- WB
Supplier Data
Western blot - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Exposure times : Lane 1 : 100 seconds; Lane 2 : 3 minutes; Lane 3 : 10 seconds; Lane 4 : 1 minute; Lane 5 : 15 seconds.
Blocking/Dilution buffer : 5% NFDM/TBST.
The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument.
All lanes:
Western blot - Anti-MSH2 antibody [EPR21017-123] (ab227941) at 1/1000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 2:
A549 (human lung carcinoma epithelial cell), whole cell lysate at 10 µg
Lane 3:
Human fetal heart lysate at 10 µg
Lane 4:
Human tonsil lysate at 10 µg
Lane 5:
A-375 (human malignant melanoma epithelial cell), whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 105 kDa
Observed band size: 104 kDa
true
- WB
Lab
Western blot - Anti-MSH2 antibody [EPR21017-123] (AB227941)
Western blot : Anti-MSH2 antibody [EPR21017-123] (ab227941) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab227941 was shown to bind specifically to MSH2. A band was observed at 104 kDa in wild-type HCT 116 cell lysates with no signal observed at this size in MSH2 knockout cell line. To generate this image, wild-type and MSH2 knockout HCT 116 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-MSH2 antibody [EPR21017-123] (ab227941) at 1/1000 dilution
Lane 1:
Wild-type HCT 116 cell lysate at 20 µg
Lane 2:
MSH2 knockout HCT 116 cell lysate at 20 µg
Lane 3:
A-375 cell lysate at 20 µg
Observed band size: 104 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-MSH2 antibody [EPR21017-123] - BSA and Azide free
Reactivity data
製品の詳細
To see more of the key markers and tools you need to study the hallmarks of cancer, including genome instability and mutation, please visit the following page.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Components are identified in mismatch repair where MSH2 forms a heterodimer with MSH6 known as the MutSα complex or with MSH3 known as the MutSβ complex. This heterodimerization is critical for the initial steps in the recognition and binding of mismatch errors on the DNA strand. MSH2 complex formation enables it to scan the DNA for errors facilitating the recruitment of additional repair proteins. The activity of MSH2 in these complexes is important in preserving the fidelity of genetic information and prevents mutations that could lead to genomic instability.
Pathways
MSH2 operates within the DNA damage response and repair pathways. The protein is a core component of the mismatch repair pathway which corrects DNA replication errors that elude proofreading activity of DNA polymerases. It interacts with other proteins such as MLH1 and PMS2 forming a synergistic function that amplifies the capacity to recognize and initiate repair of mismatches. The pathway involving MSH2 not only repairs mismatched bases but also plays a role in cell cycle control checkpoints and apoptosis evidencing its pivotal role in maintaining cell cycle integrity.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (16)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in cell and developmental biology 12:1510264 PubMed39830210
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 16: PubMed39123454
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 16:9692-9708 PubMed38843391
2024
Applications
Unspecified application
Species
Unspecified reactive species
EBioMedicine 103:105142 PubMed38691939
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 4:100883 PubMed36630951
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 12:1012168 PubMed36387191
2022
Applications
Unspecified application
Species
Unspecified reactive species
Current oncology (Toronto, Ont.) 29:4315-4331 PubMed35735454
2022
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 41:e109324 PubMed35471583
2022
Applications
Unspecified application
Species
Unspecified reactive species
Medical science monitor : international medical journal of experimental and clinical research 28:e934493 PubMed35322001
2022
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostics (Basel, Switzerland) 12: PubMed35204378
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com